about
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligoEffect of Associated Autoimmune Diseases on Type 1 Diabetes Mellitus Incidence and Metabolic Control in Children and AdolescentsA Multicenter Collaborative Study by the Korean Society of Vitiligo about Patients' Occupations and the Provoking Factors of VitiligoClinical Analysis of Thyroglobulin Antibody and Thyroid Peroxidase Antibody and their Association with Vitiligo.B cells require "nurturing" by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus.Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review.Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control studyAmniotic membrane as a scaffold for melanocyte transplantation in patients with stable vitiligo.Incidence of vitiligo in children with Graves' disease and Hashimoto's thyroiditisThe vitiligo in senegal.Autoantibodies as diagnostic and predictive markers of vitiligo.The Frequency of Autoimmune Thyroid Disease in Alopecia Areata and Vitiligo Patients.Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgarisInfluence of Pregnancy on Vitiligo Activity.Vitiligo and associated autoimmune disease: retrospective review of 300 patients.Vitiligo: what's new in the psycho-neuro-endocrine-immune connection and related treatments.Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients.Association of HLA alleles and haplotypes with vitiligo in Moroccan patients: a case-control study.Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.[Vitiligo and emotions].Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.A Case of Vitiligo after Kawasaki's DiseaseCase Report: Behçet's disease accompanied with vitiligo.A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo.Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo.T cell subpopulations and IL-2R in vitiligo.Association study between nonsense polymorphism (rs2039381, Gln71Stop) of interferon-ε and susceptibility to vitiligo in Korean population.A case series pilot study on the combination of 5-aminolevulinic acid and photodynamic therapy (ALA-PDT) for treatment of vitiligo
P2860
Q24794301-4BAD307F-646A-49F9-802D-49CEB83D1784Q26741457-B49F003D-5E89-4195-B037-9DE086BC2E1FQ33801996-9097931A-9B77-4795-9796-25CEDE4899E2Q33919364-8C152465-F9F4-415A-8ABE-ABB0028F9D9CQ33936174-9E59554D-9382-4BD9-A26A-A35128040298Q34299909-B9E196B2-CB70-4A34-8C8B-0CB5E91583E0Q34494983-C3D655FA-2875-4D1C-B4F9-775DD1EB2BB7Q35173306-66B26A81-F0A5-489A-84B9-06E4CC3F9EEDQ35666729-7B22D41A-C710-4A70-AB44-DF9201D8D86FQ35692074-7507490B-7BCB-466A-8512-AD8B63A64FCEQ35934690-42AAF3EA-A889-4407-93CB-FDA93A180B48Q36013154-7EBFC359-082A-4E35-90EB-E18260A6783CQ37371455-30C7D484-D225-435F-8F64-6F85A07D6DB9Q37634308-93B38090-0833-4D9C-94BF-09E2B9AECE21Q38025488-504B1B78-54C0-4750-BD47-7719ED9DE5B0Q38233632-34EE7BAA-A66C-4A78-AB7B-C1E32D4E74A9Q38700035-72368C0D-120D-4355-8652-A0F5C0136242Q38916380-C6BEB10B-1374-4AB0-9EB3-E5ACA11561B3Q38943432-EB19DDF8-3400-46C5-8B9D-040845A3971CQ39278444-05F8F357-B5BA-49AC-BC28-68D52C161C98Q39331724-1F3A875A-87F7-4B11-AC7E-0846F5F4EDC4Q39723783-71FFC585-70C8-4219-86AD-F53F100669C1Q40971128-65864D8B-10F0-4161-838E-D9A419AE845AQ42062212-EEC01025-71B1-4188-B7DB-68F5EDBD04F8Q46599062-91970326-0DD9-4BDB-8BBF-334C1AA5A3D7Q47333600-3E746E3D-D00C-4C5B-886A-ABF7D8FB42EEQ47435954-8E8694DE-C496-4F02-8902-687C9A491E1DQ50877365-078458D9-8189-4BF5-A59F-87CC41CDCD50Q57177590-AEBFD0EF-E701-4D64-B431-4967F89EC8A3
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Autoimmune aspects of vitiligo.
@ast
Autoimmune aspects of vitiligo.
@en
Autoimmune aspects of vitiligo.
@nl
type
label
Autoimmune aspects of vitiligo.
@ast
Autoimmune aspects of vitiligo.
@en
Autoimmune aspects of vitiligo.
@nl
prefLabel
Autoimmune aspects of vitiligo.
@ast
Autoimmune aspects of vitiligo.
@en
Autoimmune aspects of vitiligo.
@nl
P2093
P1433
P1476
Autoimmune aspects of vitiligo.
@en
P2093
P356
10.3109/08916930108994127
P577
2001-01-01T00:00:00Z